| Current Price | $16.00 | Mkt Cap | $108.6M |
|---|---|---|---|
| Open | $15.69 | P/E Ratio | -0.67 |
| Prev. Close | $16.00 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $15.52 - $16.05 | Volume | 3,008 |
| 52-Wk Range | $5.22 - $24.80 | Avg. Daily Vol. | 9,111 |
A commercial-stage biopharmaceutical company dedicated to the identification, development & commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the CNS.
| Current Price | $16.00 | Mkt Cap | $108.6M |
|---|---|---|---|
| Open | $15.69 | P/E Ratio | -0.67 |
| Prev. Close | $16.00 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $15.52 - $16.05 | Volume | 3,008 |
| 52-Wk Range | $5.22 - $24.80 | Avg. Daily Vol. | 9,111 |
The best Bull and Bear pitches based on recency and number of recommendations.
biotech w/ actual cash flow and no negatives on the EPS. Valuations are pretty high, but that is because of the hope for the big score on MS drugs.
Read the most recent pitches from players about ACOR.
Recs
benyboy
(< 20)
Submitted: 9/28/2014 10:44:57 PM :
Start Price:
$25,200.00
NASDAQ:ACOR Score:
-219.81
Jim
Recs
OKwarrior
(22.86)
Submitted: 6/9/2014 1:33:24 AM :
Start Price:
$25,588.80
NASDAQ:ACOR Score:
-220.77
biotech w/ actual cash flow and no negatives on the EPS. Valuations are pretty high, but that is because of the hope for the big score on MS drugs.
Recs
TerryFool
(< 20)
Submitted: 5/5/2014 10:50:48 AM :
Start Price:
$21,546.00
NASDAQ:ACOR Score:
-230.10
ACOR NEXT YR EPS .90 TP 40
Find the members with the highest scoring picks in ACOR.
SanDieguito (30.61) Score: +542.91
The Score Leader is the player with the highest score across all their picks in ACOR.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| SanDieguito | 30.61 | 3/31/2009 |
|
3Y | $14,479.20 | -99.89% | +443.02% | +542.91 | 0 Comment | |
| jmacn22 | 33.31 | 2/5/2009 |
|
3Y | $17,611.20 | -99.91% | +416.67% | +516.58 | 1 Comment | |
| anticitradeshort | 27.96 | 4/20/2009 |
|
NS | $13,262.40 | -99.88% | +409.57% | +509.45 | 0 Comment | |
| Nivaos | < 20 | 8/17/2009 |
|
1Y | $16,754.40 | -99.90% | +338.51% | +438.41 | 0 Comment | |
| Hogty | 88.67 | 9/1/2009 |
|
3M | $15,746.40 | -99.90% | +332.34% | +432.24 | 2 Comments | |
| BetapegAnalytics | < 20 | 8/13/2009 |
|
5Y | $17,222.40 | -99.91% | +329.15% | +429.05 | 0 Comment | |
| BuyTheDip | 26.36 | 10/2/2009 |
|
3W | $15,847.20 | -99.90% | +322.87% | +422.77 | 0 Comment | |
| dexxyru | < 20 | 10/5/2009 |
|
5Y | $16,344.00 | -99.90% | +318.26% | +418.16 | 0 Comment | |
| Phoenix748 | < 20 | 10/6/2008 |
|
NS | $14,889.60 | -99.89% | +313.06% | +412.95 | 0 Comment | |
| lanceur | 43.22 | 11/5/2009 |
|
5Y | $16,394.40 | -99.90% | +308.28% | +408.18 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
